HR (95% CI) | ||||
---|---|---|---|---|
Disease statuses | Person-yearsa | Deathsa | Model 1b | Model 2b |
Hypothyroidism women | ||||
No | 145,398 | 591 | 1.00 | 1.00 |
Undetected | 2219 | 6 | 0.94 (0.57–1.54) | 0.55 (0.25–1.23) |
Diagnosed during follow-up | 16,201 | 50 | 1.09 (0.87–1.36) | 0.98 (0.73–1.31) |
Diagnosed baseline | 10,142 | 51 | 1.30 (1.04–1.61) | 1.27 (0.95–1.69) |
Hypothyroidism men | ||||
No | 78,193 | 543 | 1.00 | 1.00 |
Undetected | 966 | 10 | 0.78 (0.46–1.30) | 0.68 (0.36–1.28) |
Diagnosed during follow-up | 4081 | 33 | 1.00 (0.72–1.37) | 1.09 (0.77–1.56) |
Diagnosed baseline | 1060 | 13 | 1.10 (0.67–1.80) | 1.27 (0.73–2.21) |
Type 2 diabetes mellitus | ||||
No | 205,330 | 830 | 1.00 | 1.00 |
Undetected | 9272 | 97 | 1.62 (1.36–1.94) | 1.60 (1.30–1.98) |
Diagnosed during follow-up | 20,018 | 173 | 1.33 (1.16–1.52) | 1.29 (1.09–1.53) |
Diagnosed baseline | 6129 | 91 | 1.84 (1.55–2.19) | 1.96 (1.57–2.44) |
Hypertension | ||||
No | 292,257 | 594 | 1.00 | 1.00 |
Undetected | 101,212 | 417 | 0.96 (0.86–1.06) | 0.95 (0.84–1.08) |
Diagnosed during follow-up | 85,004 | 597 | 1.12 (1.01–1.24) | 1.16 (1.03–1–30) |
Diagnosed baseline | 59,097 | 588 | 1.28 (1.16–1.42) | 1.32 (1.17–1.49) |